Parallel sequencing used in detection of mosaic mutations: comparison with four diagnostic DNA screening techniques A Rohlin, J Wernersson, Y Engwall, L Wiklund, J Björk, M Nordling Human mutation 30 (6), 1012-1020, 2009 | 185 | 2009 |
A mutation in POLE predisposing to a multi-tumour phenotype A Rohlin, T Zagoras, S Nilsson, U Lundstam, J Wahlström, L Hultén, ... International journal of oncology 45 (1), 77-81, 2014 | 91 | 2014 |
Expanding the genotype–phenotype spectrum in hereditary colorectal cancer by gene panel testing A Rohlin, E Rambech, A Kvist, T Törngren, F Eiengård, U Lundstam, ... Familial Cancer 16, 195-203, 2017 | 63 | 2017 |
Inactivation of promoter 1B of APC causes partial gene silencing: evidence for a significant role of the promoter in regulation and causative of familial adenomatous polyposis A Rohlin, Y Engwall, K Fritzell, K Göransson, A Bergsten, Z Einbeigi, ... Oncogene 30 (50), 4977-4989, 2011 | 59 | 2011 |
Biallelic germline nonsense variant of MLH3 underlies polyposis predisposition A Olkinuora, TT Nieminen, E Mårtensson, A Rohlin, A Ristimäki, ... Genetics in Medicine 21 (8), 1868-1873, 2019 | 58 | 2019 |
Mismatch repair gene mutation spectrum in the Swedish Lynch syndrome population K Lagerstedt-Robinson, A Rohlin, C Aravidis, B Melin, M Nordling, ... Oncology reports 36 (5), 2823-2835, 2016 | 56 | 2016 |
GREM1 and POLE variants in hereditary colorectal cancer syndromes A Rohlin, F Eiengård, U Lundstam, T Zagoras, S Nilsson, A Edsjö, ... Genes, Chromosomes and Cancer 55 (1), 95-106, 2016 | 56 | 2016 |
Clinical characterization and the mutation spectrum in Swedish adenomatous polyposis families G Kanter-Smoler, K Fritzell, A Rohlin, Y Engwall, B Hallberg, A Bergman, ... BMC medicine 6, 1-14, 2008 | 53 | 2008 |
Immune checkpoint blockade and biomarkers of clinical response in non–small cell lung cancer A Hallqvist, A Rohlin, S Raghavan Scandinavian journal of immunology 92 (6), e12980, 2020 | 18 | 2020 |
NGS targeted screening of 100 Scandinavian patients with coronal synostosis A Topa, A Rohlin, MK Andersson, A Fehr, L Lovmar, G Stenman, L Kölby American journal of medical genetics Part A 182 (2), 348-356, 2020 | 14 | 2020 |
Swedish Extended Genetic Analysis of Colorectal Neoplasia (SWEN) Study Group, Gebre-Medhin S, Nordling M, Peltomäki P. Biallelic germline nonsense variant of MLH3 underlies … A Olkinuora, TT Nieminen, E Mårtensson, A Rohlin, A Ristimäki, ... Genet Med 21, 1868-1873, 2019 | 10 | 2019 |
The outcome of targeted NGS screening in patients with syndromic forms of sagittal and pansynostosis-IL11RA is an emerging core-gene for pansynostosis A Topa, A Rohlin, MK Andersson, A Fehr, L Lovmar, G Stenman, L Kölby European Journal of Medical Genetics 65 (5), 104476, 2022 | 3 | 2022 |
PΨFinder: a practical tool for the identification and visualization of novel pseudogenes in DNA sequencing data S Abrahamsson, F Eiengård, A Rohlin, M Dávila López BMC bioinformatics 23 (1), 59, 2022 | 2 | 2022 |
Merged testing for colorectal cancer syndromes and re‐evaluation of genetic variants improve diagnostic yield: Results from a nationwide prospective cohort S Svensson, T Zagoras, C Aravidis, MS Askmalm, E Björck, Å Borg, ... Genes, Chromosomes and Cancer 61 (10), 585-591, 2022 | 1 | 2022 |
Identification of known and novel familial cancer genes in Swedish colorectal cancer families HT Helgadottir, J Thutkawkorapin, A Rohlin, M Nordling, ... International Journal of Cancer 149 (3), 627-634, 2021 | 1 | 2021 |
Hereditary Colorectal Cancer; Identification, Characterization and Classification of Mutations A Rohlin | 1 | 2015 |
The value of genome-wide analysis in craniosynostosis A Topa, A Rohlin, A Fehr, L Lovmar, G Stenman, P Tarnow, G Maltese, ... Frontiers in Genetics 14, 1322462, 2024 | | 2024 |
A multi-omics approach on hereditary colorectal cancer F Eiengard, A Rohlin, R Ellegard, P Palmeback, M Rosliden, ... EUROPEAN JOURNAL OF HUMAN GENETICS 32, 585-585, 2024 | | 2024 |
Towards routine long-read sequencing for rare disease: a national pilot study on chromosomal rearrangements J Eisfeldt, A Ameur, F Lenner, ET Berk de Boer, M Ek, J Wincent, R Vaz, ... medRxiv, 2023.12. 15.23299892, 2023 | | 2023 |
32 Identification of predictive biomarkers of clinical response to PD-1 blockade in patients with advanced non-small cell lung cancer N Dutta, E Eklund, L Akyürek, P Torstensson, V Sayin, A Rohlin, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |